F

Fennec Pharmaceuticals
D

FENC

6.26000
USD
0.34
(5.74%)
مغلق
حجم التداول
11,005
الربح لكل سهم
0
العائد الربحي
-
P/E
-18
حجم السوق
215,814,614
المقالات
المزيد

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.